INSTI ® COVID-19 Antibody Test is bioLytical’s new one-minute test, detecting antibodies to SARS-CoV-2 with high accuracy. bioLytical has received CE Mark and approval to sell the test across Europe.
The INSTI® HIV Self Test delivers highly accurate results in 60 seconds or less, the fastest home-use HIV rapid test available. FDA-approved and ready for U.S. consumers, providing a private and ...
Helping More People Know Their HIV Status National HIV Testing Day highlights the importance of knowing one's HIV status and connecting with ...
NEW YORK--(BUSINESS WIRE)--On Saturday, June 8 th, AIDS Healthcare Foundation (AHF) will make history as the first HIV testing program in New York City to use a revolutionary HIV test that provides ...
bioLytical Laboratories Inc.: INSTI HIV Self Test Earns WHO Prequalification Status for Home Testing
The newly WHO Prequalified INSTI HIV Self Test makes a mark as it expands into new markets VANCOUVER, British Columbia, Nov. 28, 2018, a world leader in rapid infectious disease tests, is pleased to ...
bioLytical Laboratories Inc., a world leader in rapid infectious disease tests and developer of the 60 second INSTI HIV test, commends Prince Harry for drawing attention to the fight against HIV.
Approval Significantly Expands U.S. Market for INSTI™ HIV-1/2 Test bioLytical Laboratories Inc., a leading manufacturer of point-of-care rapid diagnostic tests, announced today that it has received ...
RICHMOND, BC, Dec. 1, 2016 /PRNewswire/ - bioLytical Laboratories (the "Company"), a world leader in rapid infectious disease tests, announced today it is expanding the launch of its INSTI HIV Self ...
RICHMOND, British Columbia, March 18, 2025 (GLOBE NEWSWIRE) -- bioLytical Laboratories Inc. ("bioLytical”), a global leader in rapid infectious disease diagnostics, announces the launch of its INSTI® ...
VANCOUVER, British Columbia, Nov. 03, 2020 (GLOBE NEWSWIRE) — For the first time, Canadians will have access to at-home HIV self test kits. bioLytical Laboratories, a world leader in rapid infectious ...
bioLytical Laboratories Inc., a leading manufacturer of rapid point-of-care diagnostic tests, announced today that its INSTI' HIV/Syphilis Multiplex Test has been cleared for immediate market entry in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results